US Stock MarketDetailed Quotes

KALV KalVista Pharmaceuticals

Watchlist
  • 11.210
  • -0.230-2.01%
Close Apr 23 16:00 ET
472.93MMarket Cap-3592P/E (TTM)

KalVista Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
(Q3)Jan 31, 2023
(Q2)Oct 31, 2022
(Q1)Jul 31, 2022
(FY)Apr 30, 2022
(Q4)Apr 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
23.03%33.15M
14.92%29.75M
10.55%29.09M
14.76%110.87M
18.34%31.73M
0.98%26.95M
9.66%25.88M
34.84%26.32M
66.80%96.61M
48.60%26.81M
Selling and administrative expenses
54.43%10.63M
36.52%10.66M
20.37%9.79M
15.69%30.6M
2.36%7.78M
-0.91%6.88M
28.88%7.81M
39.05%8.13M
58.96%26.45M
23.24%7.6M
-General and administrative expense
54.43%10.63M
36.52%10.66M
20.37%9.79M
15.69%30.6M
2.36%7.78M
-0.91%6.88M
28.88%7.81M
39.05%8.13M
58.96%26.45M
23.24%7.6M
Research and development costs
12.26%22.52M
5.60%19.09M
6.16%19.31M
14.41%80.28M
24.66%23.95M
1.65%20.06M
3.03%18.08M
33.05%18.19M
69.95%70.17M
61.77%19.21M
Operating profit
-23.03%-33.15M
-14.92%-29.75M
-10.55%-29.09M
-14.76%-110.87M
-18.34%-31.73M
-0.98%-26.95M
-9.66%-25.88M
-34.84%-26.32M
-66.80%-96.61M
-48.60%-26.81M
Net non-operating interest income expense
-6.56%684K
72.83%776K
281.40%923K
104.77%2.23M
201.49%808K
183.72%732K
54.83%449K
-11.68%242K
20.71%1.09M
-14.65%268K
Non-operating interest income
-6.56%684K
72.83%776K
281.40%923K
104.77%2.23M
201.49%808K
183.72%732K
54.83%449K
-11.68%242K
20.71%1.09M
-14.65%268K
Other net income (expense)
-29.96%3.44M
-58.45%1.32M
-5.90%2.85M
19.33%15.73M
89.92%4.62M
24.05%4.91M
-13.27%3.18M
-3.22%3.03M
22.35%13.18M
-12.34%2.43M
Gain on sale of security
87.60%1.12M
-309.78%-1.3M
188.20%456K
105.86%90K
132.44%327K
401.52%597K
-13.21%-317K
-913.73%-517K
-281.46%-1.54M
-863.64%-1.01M
Other non- operating income (expenses)
-46.23%2.32M
-25.04%2.62M
-32.46%2.4M
6.26%15.64M
24.72%4.29M
3.78%4.31M
-11.39%3.49M
11.46%3.55M
48.26%14.72M
30.23%3.44M
Income before tax
-36.26%-29.03M
-24.23%-27.65M
-9.87%-25.32M
-12.83%-92.91M
-9.09%-26.31M
5.18%-21.3M
-13.27%-22.26M
-43.04%-23.04M
-78.05%-82.34M
-61.23%-24.11M
Income tax
0
0
Net income
-36.26%-29.03M
-24.23%-27.65M
-9.87%-25.32M
-12.83%-92.91M
-9.09%-26.31M
5.18%-21.3M
-13.27%-22.26M
-43.04%-23.04M
-78.05%-82.34M
-61.23%-24.11M
Net income continuous Operations
-36.26%-29.03M
-24.23%-27.65M
-9.87%-25.32M
-12.83%-92.91M
-9.09%-26.31M
5.18%-21.3M
-13.27%-22.26M
-43.04%-23.04M
-78.05%-82.34M
-61.23%-24.11M
Minority interest income
Net income attributable to the parent company
-36.26%-29.03M
-24.23%-27.65M
-9.87%-25.32M
-12.83%-92.91M
-9.09%-26.31M
5.18%-21.3M
-13.27%-22.26M
-43.04%-23.04M
-78.05%-82.34M
-61.23%-24.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-36.26%-29.03M
-24.23%-27.65M
-9.87%-25.32M
-12.83%-92.91M
-9.09%-26.31M
5.18%-21.3M
-13.27%-22.26M
-43.04%-23.04M
-78.05%-82.34M
-61.23%-24.11M
Basic earnings per share
-12.00%-0.84
11.11%-0.8
21.28%-0.74
0.89%-3.33
21.43%-0.77
18.48%-0.75
-12.50%-0.9
-42.42%-0.94
-38.84%-3.36
-50.77%-0.98
Diluted earnings per share
-12.00%-0.84
11.11%-0.8
21.28%-0.74
0.89%-3.33
21.43%-0.77
18.48%-0.75
-12.50%-0.9
-42.42%-0.94
-38.84%-3.36
-50.77%-0.98
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023(Q3)Jan 31, 2023(Q2)Oct 31, 2022(Q1)Jul 31, 2022(FY)Apr 30, 2022(Q4)Apr 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 23.03%33.15M14.92%29.75M10.55%29.09M14.76%110.87M18.34%31.73M0.98%26.95M9.66%25.88M34.84%26.32M66.80%96.61M48.60%26.81M
Selling and administrative expenses 54.43%10.63M36.52%10.66M20.37%9.79M15.69%30.6M2.36%7.78M-0.91%6.88M28.88%7.81M39.05%8.13M58.96%26.45M23.24%7.6M
-General and administrative expense 54.43%10.63M36.52%10.66M20.37%9.79M15.69%30.6M2.36%7.78M-0.91%6.88M28.88%7.81M39.05%8.13M58.96%26.45M23.24%7.6M
Research and development costs 12.26%22.52M5.60%19.09M6.16%19.31M14.41%80.28M24.66%23.95M1.65%20.06M3.03%18.08M33.05%18.19M69.95%70.17M61.77%19.21M
Operating profit -23.03%-33.15M-14.92%-29.75M-10.55%-29.09M-14.76%-110.87M-18.34%-31.73M-0.98%-26.95M-9.66%-25.88M-34.84%-26.32M-66.80%-96.61M-48.60%-26.81M
Net non-operating interest income expense -6.56%684K72.83%776K281.40%923K104.77%2.23M201.49%808K183.72%732K54.83%449K-11.68%242K20.71%1.09M-14.65%268K
Non-operating interest income -6.56%684K72.83%776K281.40%923K104.77%2.23M201.49%808K183.72%732K54.83%449K-11.68%242K20.71%1.09M-14.65%268K
Other net income (expense) -29.96%3.44M-58.45%1.32M-5.90%2.85M19.33%15.73M89.92%4.62M24.05%4.91M-13.27%3.18M-3.22%3.03M22.35%13.18M-12.34%2.43M
Gain on sale of security 87.60%1.12M-309.78%-1.3M188.20%456K105.86%90K132.44%327K401.52%597K-13.21%-317K-913.73%-517K-281.46%-1.54M-863.64%-1.01M
Other non- operating income (expenses) -46.23%2.32M-25.04%2.62M-32.46%2.4M6.26%15.64M24.72%4.29M3.78%4.31M-11.39%3.49M11.46%3.55M48.26%14.72M30.23%3.44M
Income before tax -36.26%-29.03M-24.23%-27.65M-9.87%-25.32M-12.83%-92.91M-9.09%-26.31M5.18%-21.3M-13.27%-22.26M-43.04%-23.04M-78.05%-82.34M-61.23%-24.11M
Income tax 00
Net income -36.26%-29.03M-24.23%-27.65M-9.87%-25.32M-12.83%-92.91M-9.09%-26.31M5.18%-21.3M-13.27%-22.26M-43.04%-23.04M-78.05%-82.34M-61.23%-24.11M
Net income continuous Operations -36.26%-29.03M-24.23%-27.65M-9.87%-25.32M-12.83%-92.91M-9.09%-26.31M5.18%-21.3M-13.27%-22.26M-43.04%-23.04M-78.05%-82.34M-61.23%-24.11M
Minority interest income
Net income attributable to the parent company -36.26%-29.03M-24.23%-27.65M-9.87%-25.32M-12.83%-92.91M-9.09%-26.31M5.18%-21.3M-13.27%-22.26M-43.04%-23.04M-78.05%-82.34M-61.23%-24.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -36.26%-29.03M-24.23%-27.65M-9.87%-25.32M-12.83%-92.91M-9.09%-26.31M5.18%-21.3M-13.27%-22.26M-43.04%-23.04M-78.05%-82.34M-61.23%-24.11M
Basic earnings per share -12.00%-0.8411.11%-0.821.28%-0.740.89%-3.3321.43%-0.7718.48%-0.75-12.50%-0.9-42.42%-0.94-38.84%-3.36-50.77%-0.98
Diluted earnings per share -12.00%-0.8411.11%-0.821.28%-0.740.89%-3.3321.43%-0.7718.48%-0.75-12.50%-0.9-42.42%-0.94-38.84%-3.36-50.77%-0.98
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg